Restoration of neutralization activity against Omicrons BA.2 and BA.5 in older adults and individuals with risk factors following the 4th-dose of SARS-CoV-2 BNT162b2 vaccine.

Amano, Masayuki; Otsu, Sachiko; Ichikawa, Yasuko; Higashi-Kuwata, Nobuyo; Matsushita, Shuzo; Shimada, Shinya; Mitsuya, Hiroaki

Amano, Masayuki; Otsu, Sachiko; Ichikawa, Yasuko; Higashi-Kuwata, Nobuyo; Matsushita, Shuzo; Shimada, Shinya; Mitsuya, Hiroaki.

Amano M; Department of Clinical Retrovirology, Joint research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Otsu S; Department of Clinical Retrovirology, Joint research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Ichikawa Y; Japan Community Health care Organization (JCHO) Kumamoto General Hospital, Kumamoto, Japan.
Higashi-Kuwata N; Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan.
Matsushita S; Department of Clinical Retrovirology, Joint research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Shimada S; Japan Community Health care Organization (JCHO) Kumamoto General Hospital, Kumamoto, Japan.
Mitsuya H; Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan.

J Infect Dis ; 2022 Sep 22.

Article in English | MEDLINE | ID: covidwho-2238658

Keywords

4th booster dose; BNT162b2 vaccine; Omicron BA 2 and BA.5; SARS-CoV-2; neutralizing activity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines / Variants Language: English Year: 2022 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google